CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-335617 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
60,915
Total Value
$2,496,997.22
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Aug 3, 2026 | Exercise/Conversion | 20,305 | $8.27 | $167,922.35 | 30,060 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Aug 3, 2026 | Sale | 20,305 | $114.70 | $2,329,074.87 | 9,755 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Stock option (right to buy) | Derivative | Aug 3, 2026 | Exercise/Conversion | 20,305 | $0.00 | $0.00 | 96,681 | Direct | โ | View Details |